Trials / Completed
CompletedNCT02538692
Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome
Traditional Chinese Medicine Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome: a Randomized Placebo-controlled Trial and a Mechanistic Study
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Chengdu University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the efficacy and safety of a traditional Chinese medication Tong-Xie-Yao-Fang for patients with diarrhea-predominant irritable bowel Syndrome (IBS-D).
Detailed description
Participants: The sample size of this trial is 118, to test an odds ratio of 3.5 at a significance of 0.05 and power of 0.8. Intervention: Tong-Xie-Yao-Fang versus placebo Data collection: Standard operation procedure will be developed for how to interviewing the participants, how to use the IBS diary, how to enter the data into the electronic case report forms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tong-Xie-Yao-Fang | Tong-Xie-Yao-Fang is a traditional Chinese formula. It is used for diarrhea management. |
| DRUG | Placebo | The placebo is the same as Tong-Xie-Yao-Fang in appearance. |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2017-01-01
- Completion
- 2017-03-01
- First posted
- 2015-09-02
- Last updated
- 2017-04-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02538692. Inclusion in this directory is not an endorsement.